You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 7, July 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bipolar Disorder
 •Schizophrenia
 •Alert me on articles by topic

Density of Glutamic Acid Decarboxylase 67 Messenger RNA–Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder

Tsung-Ung W. Woo, MD, PhD; John P. Walsh, MS; Francine M. Benes, MD, PhD

Arch Gen Psychiatry. 2004;61:649-657.

Background  Disturbances of {gamma}-aminobutyric acid interneurons in the cerebral cortex contribute to the pathophysiology of schizophrenia and bipolar disorder. The activity of these neurons is, in turn, modulated by glutamatergic inputs furnished by pyramidal neurons.

Objective  To test the hypothesis that glutamatergic inputs onto {gamma}-aminobutyric acid interneurons via the N-methyl-D-aspartate (NMDA) receptor are altered in the anterior cingulate cortex in schizophrenia and bipolar disorder.

Design  A double in situ hybridization technique was used to simultaneously label the messenger RNA (mRNA) for the NMDA NR2A subunit with 35sulfur and the mRNA for the 67-kDa isoform of the {gamma}-aminobutyric acid synthesizing enzyme glutamic acid decarboxylase (GAD67) with digoxigenin.

Setting  Postmortem human brain studies.

Participants  We studied 17 subjects with schizophrenia, 17 subjects with bipolar disorder, and 17 normal control subjects.

Results  The density of all GAD67 mRNA–containing neurons was decreased by 53% and 28%, in layers 2 and 5, respectively, in subjects with schizophrenia, whereas in subjects with bipolar disorder there was a 35% reduction in layer 2 only. For GAD67 mRNA–containing neurons that co-expressed NR2AmRNA, their numerical density was decreased by 73% and 52%, in layers 2 and 5, respectively, in subjects with schizophrenia and by 60% in layer 2 in those with bipolar disorder. In the schizophrenia group, the density of the GAD67mRNA–containing neurons that did not co-express NR2AmRNA was also decreased by 42% in layer 2. In both disease groups, the expression level of NR2AmRNA in GAD67 mRNA–containing cells was unaltered.

Conclusions  The density of {gamma}-aminobutyric acid interneurons that express the NMDA NR2Asubunit appears to be decreased in schizophrenia and bipolar disorder. Future studies will address whether subpopulations of these neurons may be differentially affected in the 2 conditions.


From the Program in Structural and Molecular Neuroscience, McLean Hospital, Belmont, Mass (Drs Woo and Benes and Mr Walsh); the Department of Psychiatry (Drs Woo and Benes) and the Program in Neuroscience (Dr Benes), Harvard Medical School, Boston, Mass; and the Massachusetts Mental Health Center, Boston (Dr Woo).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation
Dong et al.
Proc. Natl. Acad. Sci. USA 2008;105:13614-13619.
ABSTRACT | FULL TEXT  

Region-Specific Changes in Gamma and Beta2 Rhythms in NMDA Receptor Dysfunction Models of Schizophrenia
Roopun et al.
Schizophr Bull 2008;34:962-973.
ABSTRACT | FULL TEXT  

Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology
Fornito et al.
Schizophr Bull 2008;0:sbn025v1-sbn025.
ABSTRACT | FULL TEXT  

Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
Hashimoto et al.
Am. J. Psychiatry 2008;165:479-489.
ABSTRACT | FULL TEXT  

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens et al.
Science 2007;318:1645-1647.
ABSTRACT | FULL TEXT  

Searching for Unique Endophenotypes for Schizophrenia and Bipolar Disorder Within Neural Circuits and Their Molecular Regulatory Mechanisms
Benes
Schizophr Bull 2007;33:932-936.
ABSTRACT | FULL TEXT  

Effects of {gamma}-Aminobutyric Acid-Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
Menzies et al.
Arch Gen Psychiatry 2007;64:156-167.
ABSTRACT | FULL TEXT  

From The Cover: The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases
Simonini et al.
Proc. Natl. Acad. Sci. USA 2006;103:1587-1592.
ABSTRACT | FULL TEXT  

An Investigation of the Efficacy of Mood Stabilizers in Rodent Models of Prepulse Inhibition
Ong et al.
J. Pharmacol. Exp. Ther. 2005;315:1163-1171.
ABSTRACT | FULL TEXT  

Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function
Honey et al.
Brain 2005;128:2597-2611.
ABSTRACT | FULL TEXT  

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia
Dong et al.
Proc. Natl. Acad. Sci. USA 2005;102:12578-12583.
ABSTRACT | FULL TEXT  

In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
Veldic et al.
Proc. Natl. Acad. Sci. USA 2005;102:2152-2157.
ABSTRACT | FULL TEXT  

DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures
Noh et al.
Proc. Natl. Acad. Sci. USA 2005;102:1749-1754.
ABSTRACT | FULL TEXT  

Neural synchrony indexes disordered perception and cognition in schizophrenia
Spencer et al.
Proc. Natl. Acad. Sci. USA 2004;101:17288-17293.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.